Intensive, home-based and effective treatment of postnatal depression has been shown to be associated with positive child development. Postnatal depression is a common experience for women after the birth of a baby, affecting at least 1 in 10 mothers in the UK. For some mothers feeling low may last for a relatively short period of […]
Postnatal depression which persists beyond six months after birth and is severe, increases the risk of children exhibiting behavioural problems, achieving lower GCSE mathematics grades at 16 years and having depression at 18 years of age. Postnatal depression which is persistent (whether moderate or severe) increases mothers’ risk of continuing to experience depressive symptoms beyond […]
Health Data Research UK is awarding £30 million funding to six sites across the UK, including the University of Oxford, to address challenging healthcare issues through use of data science. Each site has world-class expertise; a track record in using health data to derive new knowledge, scientific discovery and insight; and works in close partnership […]
The world’s first NHS trial for a universal flu vaccine has recruited its first round of participants, with over 862 people signing up to take part since the trial launched in October 2017. This marks the end of the first phase of the trial, which will open again for new participants at the start of the winter […]
Girls who start their periods before they turn 12 are at greater risk of developing heart disease and stroke in later life, according to a new study of nearly 300,000 women in the UK by The George Institute for Global Health at the University of Oxford. Women who give birth at a young age, experience […]
Predictive genetic tool developed to better inform men whether and when to take PSA blood test. Prostate cancer detection currently relies on the prostate-specific antigen (PSA) screening blood test, which has been proven to reduce deaths from the disease. However, PSA testing is a poor screening tool because it can also produce false positive results […]
The University of Oxford, Oxford University Hospitals NHS Foundation Trust and the Patient experience healthcare company Oneview Healthcare signed a research and development (R&D) agreement for clinical pathways, following the success of a Prostate Cancer Pathway pilot. For the full story on the Nuffield Department of Surgical Sciences website
The National Institute of Health Research (NIHR) has awarded £4 million to enable state-of-the-art psychological therapy to be delivered via virtual reality (VR) in the NHS. The project, led by Daniel Freeman, NIHR Research Professor and Professor of Clinical Psychology, University of Oxford and Oxford Health NHS Foundation Trust, brings together a team of NHS trusts, universities, […]
Oxford University Hospitals has started a clinical trial which combines the use of immunotherapy with a protein-inhibiting drug for use with difficult-to-treat bowel cancer. Immunotherapy combined with checkpoint inhibitor drugs has been used successfully as treatment for several cancers, including melanoma and lung cancer, but until now has not worked so effectively on bowel cancer. […]
The new Oxford Centre for Haematology has been launched with funding from the NIHR Oxford Biomedical Research Centre (BRC), bringing together University of Oxford researchers and clinicians from Oxford University Hospitals NHS Foundation Trust. The aim of this new virtual centre is to bring people working in haematology together to improve the understanding and treatment of blood […]